ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESM..................*JBDM Ver 2.0.24 - 2999001/03125929CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120231227W173deBibliographieenBibliographyfrBibliographieEP15713532.8201504022016100320190823enenen20140592120140402GB2023122720235220170208201706202311012023442023021320231227202352A61K 39/002 20060101AFI20151013BHEP A61K 39/015 20060101ALI20151013BHEP A61K 39/29 20060101ALI20151013BHEP A61K 39/39 20060101ALI20151013BHEP A61K 39/04 20130101 FI20150527BHEP A61K2039/545 20130101 LA20160310BHEP A61K2039/55572 20130101 LA20160310BHEP A61K2039/55577 20130101 LA20160310BHEP A61P 31/06 20180101 LI20200327BHEP A61P 33/06 20180101 LI20200327BHEP A61P 37/04 20180101 LI20200331BHEP Y02A 50/30 20180101 LA20230330BGEP deNEUE VERFAHREN ZUR IMMUNISIERUNGenNOVEL METHODS FOR INDUCING AN IMMUNE RESPONSEfrMETHODES NOUVELLES POUR INDUIRE DES REPONSES IMMUNITAIRESSTOUTE J A ET AL: "A PRELIMINARY EVALUATION OF A RECOMBINANT CIRCUMSPOROZOITE PROTEIN VACCINE AGAINST PLASMODIUM FALCIPARUM MALARIA", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, US, vol. 336, no. 2, 9 January 1997 (1997-01-09), pages 86-91, XP000990284, ISSN: 0028-4793, DOI: 10.1056/NEJM199701093360202 cited in the applicationHILL ADRIAN V S: "Vaccines against malaria", PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON. SERIES B: BIOLOGICAL SCIENCES, ROYAL SOCIETY OF LONDON, LONDON, GB, vol. 366, no. 1579, 12 October 2011 (2011-10-12), pages 2806-2814, XP002700406, ISSN: 0080-4622, DOI: 10.1098/RSTB.2011.0091W. R. BALLOU: "The development of the RTS,S malaria vaccine candidate: challenges and lessons", PARASITE IMMUNOLOGY, vol. 31, no. 9, 1 September 2009 (2009-09-01), pages 492-500, XP55208451, ISSN: 0141-9838, DOI: 10.1111/j.1365-3024.2009.01143.xSTOUTE J A ET AL: "LONG-TERM EFFICACY AND IMMUNE RESPONSES FOLLOWING IMMUNIZATION WITH THE RTS,S MALARIA VACCINE", JOURNAL OF INFECTIOUS DISEASES. JID, UNIVERSITY OF CHICAGO PRESS, CHICAGO, IL, vol. 178, no. 4, 1 October 1998 (1998-10-01), pages 1139-1144, XP008046110, ISSN: 0022-1899, DOI: 10.1086/515657ELENA MATA ET AL: "Malaria Vaccine Adjuvants: Latest Update and Challenges in Preclinical and Clinical Research", BIOMED RESEARCH INTERNATIONAL, vol. 6, no. 5, 1 January 2013 (2013-01-01) , pages 599-19, XP55208483, ISSN: 2314-6133, DOI: 10.1016/j.ijpharm.2008.08.039L. C. PAOLETTI ET AL: "Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines", INFECTION AND IMMUNITY, vol. 69, no. 11, 1 November 2001 (2001-11-01), pages 6696-6701, XP55208551, ISSN: 0019-9567, DOI: 10.1128/IAI.69.11.6696-6701.2001GIOVANNI GABUTTI ET AL: "Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster", BIOMED RESEARCH INTERNATIONAL, vol. 60, no. 1, 1 January 2014 (2014-01-01), pages 13-10, XP55192849, ISSN: 2314-6133, DOI: 10.4103/0974-777X.77298BALLOU, William Ripley Jr.GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89B-1330 RixensartBEDIDIERLAURENT, Arnaud, MichelGlaxoSmithKline Biologicals S.A. Rue de l'Institut 89B-1330 RixensartBEVAN DER MOST, Robbert, GerritGlaxoSmithKline Biologicals S.A. Rue de l'Institut 89B-1330 RixensartBEGlaxoSmithKline Biologicals S.A.101843738N426001EPRue de l'Institut 891330 RixensartBEJ A Kemp LLP10166966680 Turnmill StreetLondon EC1M 5QUGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRBA20161003ME20161003EP201505742420150402enWO20151505682015100820154020231121202311272023112720231101ATBEBGDEDKEEFIFRITLTLULVMTNLPTSESIBALLOU, William Ripley Jr.GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89B-1330 RixensartBEDIDIERLAURENT, Arnaud, MichelGlaxoSmithKline Biologicals S.A. Rue de l'Institut 89B-1330 RixensartBEVAN DER MOST, Robbert, GerritGlaxoSmithKline Biologicals S.A. Rue de l'Institut 89B-1330 RixensartBEGlaxoSmithKline Biologicals S.A.101843738N426001EP-(UP)Rue de l'Institut 891330 RixensartBEJ A Kemp LLP10166966680 Turnmill StreetLondon EC1M 5QUGB